《最ich指导建议建议原则培训课件》由会员分享，可在线阅读，更多相关《最ich指导建议建议原则培训课件（122页珍藏版）》请在金锄头文库上搜索。
1、单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,最ich指导建议建议原则,#,单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,*,最ich指导建议建议原则,#,最ich指导建议建议原则,ich guidelines,2,最ich指导建议建议原则,说明,ich的论题主要分为四类，因此ich根据论题的类别不同而进行相应的编码分类：,“q”类论题：q代表quality，指那些与化工和医药，质量保证方面的相关的论题。,“s”类论题：s代表safety，指那些与实验室和动物实验，临床前研究方面的相关的论题。,3.“e”类论题：e
2、代表efficacy，指那些与人类临床研究相关的课题。,4.“m”类论题：m代表multidisciplinary,指那些不可单独划入以上三个分类的交叉涉及的论题。同时m又细分为5个小类 m1:常用医学名词（meddra）m2:药政信息传递之电子标准 m3:与临床试验相关的临床前研究时间的安排 m4:常规技术文件(ctd)m5:药物词典的数据要素和标准,3,最ich指导建议建议原则,一、quality guidelines 质量研究指导原则,harmonisation achievements in the quality area include pivotal milestones suc
3、h as the conduct of stability studies,defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on good manufacturing practice(gmp)risk management.,4,最ich指导建议建议原则,q1a-q1f,stability,稳定性,q1a(r2),stability testing of new drug substances and product
4、s,新原料药和制剂的稳定性试验,q1b,stability testing:photostability testing of new drug substances and products,新原料药和制剂的光稳定性试验,q1c,stability testing for new dosage forms,新剂型的稳定性试验,q1d,bracketing and matrixing designs for stability testing of new drug substances and products,原料药和制剂稳定性试验的交叉和矩阵设计,q1e,evaluation of st
5、ability data,稳定性数据的评估,q1f,stability data package for registration applications in climatic zones iii and iv,在气候带iii和iv，药物注册申请所提供的稳定性数据,5,最ich指导建议建议原则,q2,analytical validation,分析验证,q2(r1),validation of analytical procedures:text and methodology,分析程序的验证：正文及方法论,6,最ich指导建议建议原则,q3a-q3d,impurities,杂质,q3a(
6、r2),impurities in new drug substances,新原料药中的杂质,q3b(r2),impurities in new drug products,新制剂中的杂质,q3c(r5),impurities:guideline for residual solvents,杂质：残留溶剂指南,q3d,guideline for elemental impurities-new,q3d,implementation of guideline for elemental impurities,7,最ich指导建议建议原则,q4-q4b pharmacopoeias,药典,q4,p
7、harmacopoeias,药典,q4a,pharmacopoeial harmonisation,药典的协调,q4b,evaluation and recommendation of pharmacopoeial texts for use in the ich regions,药典内容的评估及推荐为用于ich地区,q4b,annex 1r1,residue on ignition/sulphated ash general chapter,附录1 关于灼烧残渣/灰分 常规篇,q4b,annex 2r1,test for extractable volume of parenteral pr
8、eparations general chapter,关于注射剂可提取容量测试 常规篇,q4b annex 3r1,test for particulate contamination:sub-visible particles general chapter,附录3 关于颗粒污染物测试:不溶性微粒 常规篇,q4b annex 4ar1,microbiological examination of non-sterile products:microbial enumeration tests general chapter,8,最ich指导建议建议原则,q4-q4b,pharmacopoei
9、as,药典,q4b annex 4br1,microbiological examination of non-sterile products:tests for specified micro-organisms general chapter,q4b annex 4cr1,microbiological examination of non-sterile products:acceptance criteria for pharmaceutical preparations and substances for pharmaceutical use general chapter,q4
10、b annex 5r1,disintegration test general chapter,q4b annex 6,uniformity of dosage units general chapter,q4b annex 7r2,dissolution test general chapter,q4b annex 8r1,sterility test general chapter,9,最ich指导建议建议原则,q4-q4b,pharmacopoeias,药典,q4b annex 9r1,tablet friability general chapter,q4b annex 10r1,po
11、lyacrylamide gel electrophoresis general chapter,q4b annex 11,capillary electrophoresis general chapter,q4b annex 12,analytical sieving general chapter,q4b annex 13,bulk density and tapped density of powders general chapter,q4b annex 14,bacterial endotoxins test general chapter,q4b faqs,frequently a
12、sked questions,10,最ich指导建议建议原则,q5a-q5e,quality of biotechnological products,生物技术产品的质量,q5a(r1),viral safety evaluation of biotechnology products derived from cell lines of human or animal origin,源于人或者动物细胞系的生物技术产品的病毒安全性评估,q5b,analysis of the expression construct in cells used for production of r-dna d
13、erived protein products,生物技术产品的质量：源于重组dna的蛋白质产品的生产中所用的细胞中的表达构建分析,q5c,stability testing of biotechnological/biological products,生物技术产品的质量：生物技术/生物产品的稳定性试验,q5d,derivation and characterisation of cell substrates used for production of biotechnological/biological products,用于生产生物技术/生物产品的细胞底物的起源和特征描述,q5e,c
14、omparability of biotechnological/biological products subject to changes in their manufacturing process,基于不同生产工艺的生物技术产品/生物产品的可比较性,11,最ich指导建议建议原则,q6a-q6b,specifications,规格,q6a,specifications:test procedures and acceptance criteria for new drug substances and new drug products:chemical substances,质量规格
15、：新原料药和新制剂的检验程序和可接收标准：化学物质(包括决定过程),q6b,specifications:test procedures and acceptance criteria for biotechnological/,biological products,质量规格：生物技术/生物产品的检验程序和可接收标准,12,最ich指导建议建议原则,q7,good manufacturing practice(原料药gmp规范),q7,good manufacturing practice guide for active pharmaceutical ingredients,活性药物成份的
16、gmp指南,q7 q&as,questions and answers:good manufacturing practice guide for active pharmaceutical ingredients,13,最ich指导建议建议原则,q8,pharmaceutical development药物开发,q8(r2),pharmaceutical development,药物开发,q8/9/10 q&asr4q8/q9/q10-,implementation,14,最ich指导建议建议原则,q9,quality risk management质量风险管理,q9,quality risk management,q8/9/10 q&asr4q8/q9/q10-,implementation,15,最ich指导建议建议原则,q10,pharmaceutical quality system 药物质量体系,q10,pharmaceutical quality system,药物质量体系,q8/9/10 q&asr4q8/q9/q10-,implementation,实施,16,最ic